[The Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
VKHS is an inflammatory system disease with a subacute chronic course. It has a very variable, selective involvement of certain pigment cells of the eye, skin, inner ear, and meninges. Due in part to the fact that its symptoms are responsive to immunosuppressive therapy, pathogenesis as an autoimmune disease is considered. The clinical course of one of our patients is discussed. Early diagnosis of VKHS, although often very difficult, is mandatory for appropriate and timely treatment.
Menger
H
H
Neurologische Klinik, Wuppertal.
Neukäter
W
W
Kroll
S
S
Jörg
J
J
D000328:Adult; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D001379:Azathioprine / Q000008:administration & dosage; D003348:Cortisone / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005451:Fluorescein Angiography; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008279:Magnetic Resonance Imaging; D008297:Male; D014607:Uveomeningoencephalitic Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D014794:Visual Fields / Q000187:drug effects
D001379:Azathioprine; D003348:Cortisone
Das uveomeningoenzephalitische Syndrom Vogt-Koyanagi-Harada.